Trades on 2 secondary markets

Dren Bio

Dren Bio is a clinical-stage biopharmaceutical company based in Foster City, California, focused on the discovery and development of novel antibody therapeutics that selectively deplete pathogenic cells and other disease-causing agents. Its proprietary Targeted Myeloid Engager and Phagocytosis Platf

minimal 12.3 / 100 0 APIs View provider profile →

Company Biopharmaceutical Biotechnology Antibody Therapeutics Oncology Autoimmune

Dren Bio is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.